(1-Methoxycyclopropyl)methanamine hydrochloride, 97%, 500mg

3-(Chloromethyl)-2-fluoropyridine, 95.0%, 1g

EDTA disodium salt solution, ROTI® volume 0.1 mol/l - 0.1 N, ampoule, 1 piece

Neu5Gc alpha(2-3)Gal beta MP Glycoside>95.0%(HPLC)5mg

Methyl 2-chloro-5-hydroxybenzoate, 95.0%, 10g

(2E,4E)-5-(4-(Dimethylamino)phenyl)penta-2,4-dienoic acid, 98%, 250mg

1-(2-Isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one, 97.0%, 1g

2,5-Dioxopyrrolidin-1-yl 2-{2-[(2,5-dioxopyrrolidin-1-yl)oxy]-2-oxoethoxy}acetate, 98.0%, 5g

2-Phenylcyclohexanone, 95.0%, 1g

(1,3-Dimethyl-1H-indazol-5-yl)boronic acid, 95.0%, 100mg

7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde, 98%, 10mg

2,6-Dichloro-N,N-dimethylpyrimidin-4-amine, 95%, 250mg

6-Fluoro-1-methylindolin-2-one, 97%, 1g